Mostrando entradas con la etiqueta NICE. Mostrar todas las entradas
Mostrando entradas con la etiqueta NICE. Mostrar todas las entradas

27.10.15

Guías NICE




Guías NICE de Agosto
Reference Guidance Programme Topic
IPG530 Transcranial direct current stimulation (tDCS) for depression

Interventional procedure guidance
Depression
IPG531 Preoperative high dose rate brachytherapy for rectal cancer

Interventional procedure guidance

Colorectal cancer

NG17

Type 1 diabetes in adults: diagnosis and management

Guideline

Diabetes
NG18
Diabetes (type 1 and type 2) in children and young people: diagnosis and management
Guideline
Diabetes


NG19

Diabetic foot problems: prevention and management

Guideline

Diabetes

TA352


Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy



Technology appraisal 
guidance


Inflammatory bowel disease


TA353


Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)
Technology appraisal
Ovarian cancer
TA354

Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism



Technology appraisal guidance


Embolism and thrombosis

NG15

Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use

Guideline



Medicines management: general and other
Guías NICE de Septiembre
IPG532
Low energy contact X ray brachytherapy (the Papillon technique) for early stage rectal cancer

Interventional procedure guidance
Colorectal cancer
MTG27
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C

Medical technology guidance
Chronic liver disease
TA355 Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation

Technology appraisal guidance
Heart rhythm conditions
TA356
Ruxolitinib for treating polycythaemia vera (terminated
appraisal)

Technology appraisal
Blood conditions
NG21
Home care: delivering personal care and practical support to older people living in their own homes
Guideline
Carers
MTG26
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia

Medical technology guidance
Lower urinary tract symptoms

QS100
Cardiovascular risk assessment and lipid modification
Quality standard
Lipid disorders
QS99 Secondary prevention after a myocardial infarction
Quality standard
Acute coronary syndromes
IPG279 Autologous blood injection for tendinopathy
Interventional procedure guidance
IPG125 Posterior infracoccygeal sacropexy for vaginal vault prolapse

Interventional procedure guidance
NG20 Coeliac disease: recognition, assessment and management
Guideline
Coeliac disease
MT In development  HumiGard Surgical Humidification System for the prevention of inadvertent perioperative hypothermia

Medical technology guidance
Surgical care



29.7.15

Guías NICE julio 2015




Reference Guidance Programme Topic
MTG25 The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites Medical technology guidance Infections: general and other
QS92 Smoking: harm reduction Quality standards Smoking and tobacco
QS93 Atrial fibrillation: treatment and management Quality standards Heart rhythm conditions
TA347 Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer Technology appraisal guidance Lung cancer
TA346 Aflibercept for treating diabetic macular oedema Technology appraisal guidance Macular oedema and retinal vein occlusion
TA348 Everolimus for preventing organ rejection in liver transplantation Technology appraisal guidance Liver conditions: general and other
TA350 Secukinumab for treating moderate to severe plaque psoriasis Technology appraisal guidance Psoriasis
IPG528 Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section Interventional procedure guidance Intrapartum care
IPG529 Joint distraction for knee osteoarthritis without alignment correction Interventional procedure guidance Knee conditions
TA349 Dexamethasone intravitreal implant for treating diabetic macular oedema Technology appraisal guidance Macular oedema and retinal vein occlusion
TA351 Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal) Technology appraisal guidance Acute coronary syndromes
TA345 Naloxegol for treating opioid‑induced constipation Technology appraisal guidance Constipation
QS94 Obesity: prevention and lifestyle weight management in children and young people Quality standards Diet, nutrition and obesity
QS96 Dyspepsia and gastro‑oesophageal reflux disease in adults: investigation and management Quality standards Digestive tract conditions: general and other
QS95 Bipolar disorder in adults Quality standards Bipolar disorder
QSD In development  Maternal and child nutrition - improving nutritional status Quality standard Infants and neonates
MPG In development  Antimicrobial stewardship Unclassified Antibiotic use
QSD In development  Drug allergy - diagnosis and management Quality standard Blood and immune system conditions: general and other
CG In development  Melanoma Guidelines Skin cancer

2.7.15

Guías NICE, abril, mayo y junio de 2015



 Enlace a todas las guías por especialidad
Abril

Reference Guidance Programme Topic
STA In development  Systemic lupus erythematosus (autoantibody-positive) - belimumab [ID416]
Technology appraisal guidance
Systemic lupus erythematosus






Mayo


Junio


Reference Guidance Programme Topic
NG13 Workplace policy and management practices to improve the health and wellbeing of employees  Guideline Workplaces 
NG12 Suspected cancer: recognition and referral  Guideline Cervical cancer 
SFCQS88 NICE support for commissioning for personality disorders: borderline and antisocial  Support for commissioning Personality disorders 
TA339 Omalizumab for previously treated chronic spontaneous urticaria  Technology appraisal guidance Skin conditions: general and other 
TA342 Vedolizumab for treating moderately to severely active ulcerative colitis  Technology appraisal guidance Inflammatory bowel disease 
TA341 Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism  Technology appraisal guidance Embolism and thrombosis 
TA340 Ustekinumab for treating active psoriatic arthritis (rapid review of technology appraisal guidance 313)  Technology appraisal guidance Arthritis 
IPG519 Insertion of an epiretinal prosthesis for retinitis pigmentosa  Interventional procedure guidance Eye conditions: general and other 
IPG521 Suture fixation of acute disruption of the distal tibiofibular syndesmosis  Interventional procedure guidance Musculoskeletal conditions: general and other 
IPG523 Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis  Interventional procedure guidance Embolism and thrombosis 
NG8 Anaemia management in people with chronic kidney disease  Guideline Blood conditions 
DG17 Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index  Diagnostics guidance Prostate cancer 
TA343 Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia  Technology appraisal guidance Blood and bone marrow cancers 
TA344 Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia  Technology appraisal guidance Blood and bone marrow cancers 
IPG520 Radiofrequency ablation for gastric antral vascular ectasia  Interventional procedure guidance Upper gastrointestinal bleeding 
IPG524 Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism  Interventional procedure guidance Embolism and thrombosis 
IPG522 Hysteroscopic morcellation of uterine leiomyomas (fibroids)  Interventional procedure guidance Endometriosis and fibroids 
QS90 Urinary tract infections in adults  Quality standards Urinary tract infection 
QS91 Prostate cancer  Quality standards Prostate cancer 
QS87 Osteoarthritis  Quality standards Arthritis 
QS88 Personality disorders: borderline and antisocial  Quality standards Personality disorders 
QS89 Pressure ulcers  Quality standards Pressure ulcers 
IPG525 Electrotherapy for the treatment of haemorrhoids  Interventional procedure guidance Haemorrhoids and other anal conditions 
IPG526 Cyanoacrylate glue occlusion for varicose veins  Interventional procedure guidance Varicose veins 
IPG527 Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache  Interventional procedure guidance Headaches 
STA In development  Hepatitis C (chronic) - ledipasvir-sofosbuvir [ID742]  Technology appraisal guidance Hepatitis 




TA344 Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia  Technology appraisal guidance Blood and bone marrow cancers 
IPG520 Radiofrequency ablation for gastric antral vascular ectasia  Interventional procedure guidance Upper gastrointestinal bleeding 
IPG524 Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism  Interventional procedure guidance Embolism and thrombosis 
IPG522 Hysteroscopic morcellation of uterine leiomyomas (fibroids)  Interventional procedure guidance Endometriosis and fibroids 
QS90 Urinary tract infections in adults  Quality standards Urinary tract infection 
QS91 Prostate cancer  Quality standards Prostate cancer 
QS87 Osteoarthritis  Quality standards Arthritis 
QS88 Personality disorders: borderline and antisocial  Quality standards Personality disorders 
QS89 Pressure ulcers  Quality standards Pressure ulcers 
IPG525 Electrotherapy for the treatment of haemorrhoids  Interventional procedure guidance Haemorrhoids and other anal conditions 
IPG526 Cyanoacrylate glue occlusion for varicose veins  Interventional procedure guidance Varicose veins 
IPG527 Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache  Interventional procedure guidance Headaches 
STA In development  Hepatitis C (chronic) - ledipasvir-sofosbuvir [ID742]  Technology appraisal guidance Hepatitis 
























27.3.15

Guías NICE, enero, febrero y marzo de 2015

Guías de enero y febrero (pinchar en los enlaces correpondientes)
Si lo que desea es localizar guías por tema, pinche en este enlace

MARZO
Reference Guidance Programme Topic
IPG515 Insertion of a balloon device to disimpact an engaged fetal head before an emergency caesarean section
Interventional procedure guidance
Intrapartum care
IPG517 Insertion of endobronchial nitinol coils to improve lung function in emphysema
Interventional procedure guidance
Chronic obstructive pulmonary disease
QS84 Physical activity: encouraging activity in all people in contact with the NHS
Quality standards
Physical activity
TA337 Rifaximin for preventing episodes of overt hepatic encephalopathy
Technology appraisal guidance
Liver conditions: general and other
QS85 Managing medicines in care homes
Quality standards
Medicines management: general and other
TA336 Empagliflozin in combination therapy for treating type 2 diabetes
Technology appraisal guidance
Diabetes
QS82 Smoking: reducing tobacco use
Quality standards
Smoking and tobacco
QS86 Falls in older people: assessment after a fall and preventing further falls
Quality standards
Injuries, accidents and wounds: general and other
TA338 Pomalidomide for relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomib
Technology appraisal guidance
Blood and bone marrow cancers
QS83 Alcohol: preventing harmful alcohol use in the community
Quality standards
Communities
IPG514 Transanal total mesorectal excision of the rectum
Interventional procedure guidance
Colorectal cancer
IPG516 Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation
Interventional procedure guidance
Cardiovascular conditions: general and other
IPG518 Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes
Interventional procedure guidance
Diabetes
MTG24 The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters
Medical technology guidance
Surgical care
TA335 Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome
Technology appraisal guidance
Acute coronary syndromes
IPG512 Implantation of a shock or load absorber for mild to moderate symptomatic medial knee osteoarthritis
Interventional procedure guidance
Knee conditions
NG7 Maintaining a healthy weight and preventing excess weight gain among adults and children
Guideline
Diet, nutrition and obesity
NG6 Excess winter deaths and morbidity and the health risks associated with cold homes
Guideline
Vulnerable groups
NG5 Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes
Guideline
Medicines management: general and other
CG28 Depression in children and young people: Identification and management in primary, community and secondary care
Clinical guidelines
Children and young people